Veterinary Medicines

Biocan R

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Download as PDF

Product identification

Medicine name:
Biocan R
Biocan R vakcina A.U.V.
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
  • Dog
  • Cat
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Horse
  • Ferret
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)/millilitre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • The vaccine is supplied in Type I glass vials complying with Ph Eur, sealed with a rubber stopper and aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 2448/X/08 MgSzH ÁTI
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0107/001
Concerned member states:
  • Cyprus
  • Estonia
  • Slovenia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 21/12/2021
Download